checkAd

     113  0 Kommentare Immunome to Acquire Antibody-Related Assets and Materials from Atreca - Seite 2

    Lesen Sie auch


    The Immunome Stock at the time of publication of the news with a raise of +1,17 % to 9,50USD on Nasdaq stock exchange (26. Dezember 2023, 13:50 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Immunome to Acquire Antibody-Related Assets and Materials from Atreca - Seite 2 Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it entered into a definitive asset purchase agreement with Atreca, Inc. (Nasdaq: BCEL) to …